Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Ltd

LINCOLN

 520.38
 2.30
0.44%
Healthcare
 0.00
(%)1D
Updated: 07 Oct 2025, 03:31:13 pm IST
Stock Score
Open Price
 519.94
Prev. Close
 518.08
 515.77
Day Low
 522.76
Day High

 499.00
52 Week Low
 979.50
52 Week High

Quick Bite

Price To Earnings Ratio

12.66

Sector PE

75.84

PB Ratio

1.55

Sector PB

5.79

EPS

41.11

Dividend Yield

0.33

Today's Volume

12.241 K

5 Day Avg. Volume

12.901 K

PEG Ratio

-1.08

Market Cap.

₹ 1,070.00 Cr.

About Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Limited is engaged in the business of manufacturing and trading of pharmaceutical products like medicines, injections and other related products. The Company's product categories include tablets, capsules, liquid injection, cream in tubes, eye/ear drops, dry power injection, liquid injection, and pharma products. It offers products for anti-infective, respiratory system, gynecology, cardio and CNS (central nervous system), antibacterial, anti-diabetic, and anti-malaria. The Company serves approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia, and 26 states across India. The Company's products include ARHL Tablet (used to treat chloroquine resistant falciparum malaria symptoms), Ibuprofen Tablet (used to treat pain, fever, and inflammation), Dolomol Tablet (used to treat aches and pains), Namcold Tablet (used to treat common cold symptoms), and Tinnex Capsule used to treat tinnitus.

Lincoln Pharmaceuticals Ltd FAQs

How to Buy Lincoln Pharmaceuticals Ltd Share?

up
To purchase Lincoln Pharmaceuticals Ltd shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Lincoln Pharmaceuticals Ltd (ticker symbol: LINCOLN) on the trading platform provided by your broker and purchase the shares.

What's Lincoln Pharmaceuticals Ltd share price today?

up
The stock price of Lincoln Pharmaceuticals Ltd as of 07 Oct 2025 is ₹520.38

What is the Market Cap of Lincoln Pharmaceuticals Ltd?

up
Market capitalisation represents the total market value of a company's outstanding shares. As of 07 Oct 2025, Lincoln Pharmaceuticals Ltd (ticker symbol: LINCOLN) has a market capitalisation of approximately ₹10,70,00,00,000.00

What is the PE and PB ratio of Lincoln Pharmaceuticals Ltd?

up
Lincoln Pharmaceuticals Ltd Ltd's price-to-book ratio as of 07 Oct 2025 is 1.55, reflecting the market's valuation compared to its asset value. As of 07 Oct 2025, the trailing twelve months P/E (price-to-earnings) ratio is 12.66, indicating the market values the company at around ₹12.66 for every ₹1 of earnings

What is the 52 Week High and Low of Lincoln Pharmaceuticals Ltd Share?

up
Lincoln Pharmaceuticals Ltd Ltd (LINCOLN) hit its 52-week high at ₹979.50, and its 52-week low at ₹499.00.
Begin your investment journey today
Login/Register
Start Now